Oncology Diagnostics

Dallas, Texas, September 1, 2026 Cizzle Bio, Inc. has announced the publication of a new peer-reviewed study providing additional...

Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...

Fort Myers, Florida – August 26, 2026 NeoGenomics announced that its RaDaR ST molecular residual disease (MRD) assay has...

Houston, USA — August 13, 2026 Cerenome, Inc. announced that its wholly owned subsidiary CNSide Diagnostics, LLC has signed...

MADISON, Wis. – July 24, 2026 Elephas Biosciences Corporation has unveiled new preclinical data demonstrating that its elive™ functional...

Houston, Texas, USA | July 21, 2026 Plus Therapeutics, through its wholly owned subsidiary CNSide Diagnostics, announced a regional...

SYDNEY, Australia & INCHEON, South Korea, July 16, 2026 Organon and Samsung Bioepis have expanded their longstanding partnership through...

SALT LAKE CITY, July 20, 2026 ARUP Laboratories has introduced ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry,...

BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...

HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...